Nu-Med Plus (NUMD) Common Equity (2011 - 2025)
Nu-Med Plus (NUMD) posted Common Equity of -$271278.0 for Q4 2025, down 4.88% sequentially from -$258660.0 in Q3 2025, and down 26.12% YoY from -$367184.8 in Q4 2024.
Nu-Med Plus (NUMD) Common Equity (2011 - 2025) Analysis & Trends
Nu-Med Plus has reported Common Equity for 15 years, with the latest figure at -$271278.0 in Q4 2025.
- Quarterly Common Equity fell 26.12% year-over-year to -$271278.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$271278.0 (down 26.12% YoY) and the FY2025 annual result came in at -$271278.0, down 26.12% from the prior year.
- Common Equity declined to -$271278.0 in Q4 2025 per NUMD's latest filing, from -$258660.0 in the prior quarter.
- Over five years, Common Equity peaked at $190955.0 in Q1 2021 and troughed at -$271278.0 in Q4 2025.
- A 5-year average of -$152677.1 and a median of -$177220.5 in 2024 frame the typical range for Common Equity.
- The sharpest annual moves came in 2021 and 2022: Common Equity soared 151.99% in 2021, then sank 14865.54% in 2022.
- Over 5 years, Common Equity stood at -$132358.0 in 2021, then jumped by 52.38% to -$63025.0 in 2022, then tumbled by 132.85% to -$146751.0 in 2023, then plunged by 46.57% to -$215096.0 in 2024, then dropped by 26.12% to -$271278.0 in 2025.
- According to Business Quant data, Common Equity over the past three periods registered -$271278.0, -$258660.0, and -$246694.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.34 Bn | 7.27 Bn | 51.76 Bn |
| 2 | Stryker | 127.40 Bn | 123.93 Bn | 4.50 Bn | 23.99 Bn |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | 50.07 Bn |
| 4 | Boston Scientific | 73.24 Bn | 72.71 Bn | 3.85 Bn | 25.17 Bn |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.70 Bn | 1.35 Bn | 10.72 Bn |
| 6 | Dexcom | 34.39 Bn | 32.44 Bn | 830.00 Mn | 2.62 Bn |
| 7 | GE HealthCare Technologies | 33.87 Bn | 31.76 Bn | 2.18 Bn | 10.99 Bn |
| 8 | Koninklijke Philips | 26.34 Bn | 23.02 Bn | 4.55 Bn | 13.31 Bn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 7.22 Bn |
| 10 | Nu-Med Plus | 2.03 Mn | 2.02 Mn | - | -267,486.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -271,278.00 |
| Sep 30, 2025 | -258,660.00 |
| Jun 30, 2025 | -246,694.00 |
| Mar 31, 2025 | -235,029.00 |
| Dec 31, 2024 | -215,096.00 |
| Sep 30, 2024 | -204,541.00 |
| Jun 30, 2024 | -185,864.00 |
| Mar 31, 2024 | -168,577.00 |
| Dec 31, 2023 | -146,751.00 |
| Sep 30, 2023 | -131,955.00 |
| Jun 30, 2023 | -115,549.00 |
| Mar 31, 2023 | -91,229.00 |
| Dec 31, 2022 | -63,025.00 |
| Sep 30, 2022 | -270,131.00 |
| Jun 30, 2022 | -247,081.00 |
| Mar 31, 2022 | -189,011.00 |
| Dec 31, 2021 | -132,358.00 |
| Sep 30, 2021 | -70,017.00 |
| Jun 30, 2021 | -1,651.00 |
| Mar 31, 2021 | 190,955.00 |